Zobrazeno 1 - 8 of 8 pro vyhledávání: '"Berg AVD"'
1
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
2
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
3
Akademický článek
Efficient and economic protein labeling for NMR in mammalian expression systems: Application to a preT-cell and T-cell receptor protein.
Autor: Mallis RJ; Laboratory of Immunobiology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Dermatology, Harvard Medical School, Boston, Massachusetts, USA., Lee JJ; Laboratory of Immunobiology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Berg AVD; Thermo Fisher Scientific, Frederick, Maryland, USA., Brazin KN; Laboratory of Immunobiology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA., Viennet T; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts, USA., Zmuda J; Thermo Fisher Scientific, Frederick, Maryland, USA., Cross M; Thermo Fisher Scientific, Frederick, Maryland, USA., Radeva D; Faculty of Chemistry and Pharmacy, Sofia University, Sofia, Bulgaria., Rodriguez-Mias R; Department of Genome Sciences, University of Washington, Seattle, Washington, USA., Villén J; Department of Genome Sciences, University of Washington, Seattle, Washington, USA., Gelev V; Faculty of Chemistry and Pharmacy, Sofia University, Sofia, Bulgaria., Reinherz EL; Laboratory of Immunobiology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA., Arthanari H; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts, USA.
Publikováno v: Protein science : a publication of the Protein Society [Protein Sci] 2024 Apr; Vol. 33 (4), pp. e4950.
Zobrazit plný text záznamu
4
Akademický článek
Fresh for Less: Cross-Sector Collaboration for Funding, Implementation, and Evaluation of a Local Initiative to Improve Equitable Healthy Food Access.
Autor: Janda KM, Nielsen A, Phelps A, Helman H, Abel A, Benz S, Pulido CL, Helfman S, Ranjit N, Berg AVD
Publikováno v: Journal of health care for the poor and underserved [J Health Care Poor Underserved] 2022; Vol. 33 (4S), pp. 83-106.
Zobrazit plný text záznamu
5
Akademický článek
Erratum: Krayem, M., et al. Kinome Profiling to Predict Sensitivity to MAPK Inhibition in Melanoma and to Provide New Insights into Intrinsic and Acquired Mechanism of Resistance Short Title: Sensitivity Prediction to MAPK Inhibitors in Melanoma. Cancers 2020, 12 , 512.
Autor: Krayem M; Laboratory of Oncology and Experimental Surgery, Institut Jules Bordet, Université Libre de Bruxelles, 1000 Brussels, Belgium., Aftimos P; Medical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles, 1000 Brussels, Belgium., Najem A; Laboratory of Oncology and Experimental Surgery, Institut Jules Bordet, Université Libre de Bruxelles, 1000 Brussels, Belgium., Hooven TVD; PamGene International BV, 5211HH 's-Hertogenbosch, The Netherlands., Berg AVD; PamGene International BV, 5211HH 's-Hertogenbosch, The Netherlands., Hovestad-Bijl L; PamGene International BV, 5211HH 's-Hertogenbosch, The Netherlands., Wijn R; PamGene International BV, 5211HH 's-Hertogenbosch, The Netherlands., Hilhorst R; PamGene International BV, 5211HH 's-Hertogenbosch, The Netherlands., Ruijtenbeek R; PamGene International BV, 5211HH 's-Hertogenbosch, The Netherlands., Sabbah M; Laboratory of Oncology and Experimental Surgery, Institut Jules Bordet, Université Libre de Bruxelles, 1000 Brussels, Belgium., Kerger J; Medical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles, 1000 Brussels, Belgium., Awada A; Laboratory of Oncology and Experimental Surgery, Institut Jules Bordet, Université Libre de Bruxelles, 1000 Brussels, Belgium.; Medical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles, 1000 Brussels, Belgium., Journe F; Laboratory of Oncology and Experimental Surgery, Institut Jules Bordet, Université Libre de Bruxelles, 1000 Brussels, Belgium., Ghanem GE; Laboratory of Oncology and Experimental Surgery, Institut Jules Bordet, Université Libre de Bruxelles, 1000 Brussels, Belgium.
Publikováno v: Cancers [Cancers (Basel)] 2020 Oct 14; Vol. 12 (10). Date of Electronic Publication: 2020 Oct 14.
Zobrazit plný text záznamu
6
Akademický článek
Primary and acquired resistance mechanisms to immune checkpoint inhibition in Hodgkin lymphoma.
Autor: Veldman J; Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, 9700RB Groningen, the Netherlands., Visser L; Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, 9700RB Groningen, the Netherlands., Berg AVD; Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, 9700RB Groningen, the Netherlands., Diepstra A; Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, 9700RB Groningen, the Netherlands. Electronic address: a.diepstra@umcg.nl.
Publikováno v: Cancer treatment reviews [Cancer Treat Rev] 2020 Jan; Vol. 82, pp. 101931. Date of Electronic Publication: 2019 Nov 11.
Zobrazit plný text záznamu
7
Akademický článek
XIST -Promoter Demethylation as Tissue Biomarker for Testicular Germ Cell Tumors and Spermatogenesis Quality.
Autor: Lobo J; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS Utrecht, The Netherlands. joaomachadolobo@gmail.com.; Department of Pathology, Portuguese Oncology Institute of Porto (IPOP), R. Dr. António Bernardino de Almeida, 4200-072 Porto, Portugal. joaomachadolobo@gmail.com.; Cancer Biology and Epigenetics Group, Research Center of Portuguese Oncology Institute of Porto (GEBC CI-IPOP) and Porto Comprehensive Cancer Center (P.CCC), R. Dr. António Bernardino de Almeida, 4200-072 Porto, Portugal. joaomachadolobo@gmail.com.; Department of Pathology and Molecular Immunology, Institute of Biomedical Sciences Abel Salazar, University of Porto (ICBAS-UP), Rua Jorge Viterbo Ferreira 228, 4050-513 Porto, Portugal. joaomachadolobo@gmail.com., Nunes SP; Cancer Biology and Epigenetics Group, Research Center of Portuguese Oncology Institute of Porto (GEBC CI-IPOP) and Porto Comprehensive Cancer Center (P.CCC), R. Dr. António Bernardino de Almeida, 4200-072 Porto, Portugal. sandra22nunes@gmail.com., Gillis AJM; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS Utrecht, The Netherlands. a.j.m.gillis@prinsesmaximacentrum.nl., Barros-Silva D; Cancer Biology and Epigenetics Group, Research Center of Portuguese Oncology Institute of Porto (GEBC CI-IPOP) and Porto Comprehensive Cancer Center (P.CCC), R. Dr. António Bernardino de Almeida, 4200-072 Porto, Portugal. daniela.barros.silva94@gmail.com., Miranda-Gonçalves V; Cancer Biology and Epigenetics Group, Research Center of Portuguese Oncology Institute of Porto (GEBC CI-IPOP) and Porto Comprehensive Cancer Center (P.CCC), R. Dr. António Bernardino de Almeida, 4200-072 Porto, Portugal. verammgoncalves@hotmail.com., Berg AVD; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS Utrecht, The Netherlands. ritaguimaraes.apct@gmail.com., Cantante M; Department of Pathology, Portuguese Oncology Institute of Porto (IPOP), R. Dr. António Bernardino de Almeida, 4200-072 Porto, Portugal. marianacantantecf@gmail.com.; Cancer Biology and Epigenetics Group, Research Center of Portuguese Oncology Institute of Porto (GEBC CI-IPOP) and Porto Comprehensive Cancer Center (P.CCC), R. Dr. António Bernardino de Almeida, 4200-072 Porto, Portugal. marianacantantecf@gmail.com., Guimarães R; Department of Pathology, Portuguese Oncology Institute of Porto (IPOP), R. Dr. António Bernardino de Almeida, 4200-072 Porto, Portugal. ritaguimaraes.apct@gmail.com.; Cancer Biology and Epigenetics Group, Research Center of Portuguese Oncology Institute of Porto (GEBC CI-IPOP) and Porto Comprehensive Cancer Center (P.CCC), R. Dr. António Bernardino de Almeida, 4200-072 Porto, Portugal. ritaguimaraes.apct@gmail.com., Henrique R; Department of Pathology, Portuguese Oncology Institute of Porto (IPOP), R. Dr. António Bernardino de Almeida, 4200-072 Porto, Portugal. henrique@ipoporto.min-saude.pt.; Cancer Biology and Epigenetics Group, Research Center of Portuguese Oncology Institute of Porto (GEBC CI-IPOP) and Porto Comprehensive Cancer Center (P.CCC), R. Dr. António Bernardino de Almeida, 4200-072 Porto, Portugal. henrique@ipoporto.min-saude.pt.; Department of Pathology and Molecular Immunology, Institute of Biomedical Sciences Abel Salazar, University of Porto (ICBAS-UP), Rua Jorge Viterbo Ferreira 228, 4050-513 Porto, Portugal. henrique@ipoporto.min-saude.pt., Jerónimo C; Cancer Biology and Epigenetics Group, Research Center of Portuguese Oncology Institute of Porto (GEBC CI-IPOP) and Porto Comprehensive Cancer Center (P.CCC), R. Dr. António Bernardino de Almeida, 4200-072 Porto, Portugal. carmenjeronimo@ipoporto.min-saude.pt.; Department of Pathology and Molecular Immunology, Institute of Biomedical Sciences Abel Salazar, University of Porto (ICBAS-UP), Rua Jorge Viterbo Ferreira 228, 4050-513 Porto, Portugal. carmenjeronimo@ipoporto.min-saude.pt., Looijenga LHJ; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS Utrecht, The Netherlands. l.looijenga@prinsesmaximacentrum.nl.; Department of Pathology, Lab. for Exp. Patho-Oncology (LEPO), Erasmus MC-University Medical Center Rotterdam, Cancer Institute, Be-432A, PO Box 2040, 3000 CA Rotterdam, The Netherlands. l.looijenga@prinsesmaximacentrum.nl.
Publikováno v: Cancers [Cancers (Basel)] 2019 Sep 17; Vol. 11 (9). Date of Electronic Publication: 2019 Sep 17.
Zobrazit plný text záznamu
8
Akademický článek
Community gardening, community farming and other local community-based gardening interventions to prevent overweight and obesity in high-income and middle-income countries: protocol for a systematic review.
Autor: Heise TL; Institute for Public Health and Nursing Research - IPP, Health Sciences Bremen, University of Bremen, Bremen, Germany.; Research Group for Evidence-Based Public Health, Leibniz Institute for Prevention Research and Epidemiology - BIPS, Bremen, Germany., Romppel M; Institute for Public Health and Nursing Research - IPP, Health Sciences Bremen, University of Bremen, Bremen, Germany., Molnar S; Department of Non-Drug Interventions, Institute for Quality and Efficiency in Health Care - IQWiG, Cologne, Germany., Buchberger B; Institute for Health Care Management and Research, University of Duisburg-Essen, Essen, Germany., Berg AVD; Faculty of Spatial Sciences, Department of Cultural Geography, University of Groningen, Groningen, The Netherlands., Gartlehner G; Department for Evidence-based Medicine and Clinical Epidemiology, Danube University Krems, Krems, Austria.; RTI-International, Research Triangle Park, North Carolina, USA., Lhachimi SK; Institute for Public Health and Nursing Research - IPP, Health Sciences Bremen, University of Bremen, Bremen, Germany.; Research Group for Evidence-Based Public Health, Leibniz Institute for Prevention Research and Epidemiology - BIPS, Bremen, Germany.
Publikováno v: BMJ open [BMJ Open] 2017 Jun 15; Vol. 7 (6), pp. e016237. Date of Electronic Publication: 2017 Jun 15.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje